Status:
NO_LONGER_AVAILABLE
Request for Single Patient IND for Compassionate/Emergency Use of Tocilizumab
Lead Sponsor:
University of Oklahoma
Collaborating Sponsors:
Hoffmann-La Roche
Conditions:
Juvenile Idiopathic Arthritis
Eligibility:
MALE
11-12 years
Brief Summary
Application for Compassionate Use of Tocilizumab in a Boy with Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) Unresponsive to All Licensed Medications.
Detailed Description
This trial is for a single subject with juvenile idiopathic arthritis unresponsive to all licensed treatments for JIA, and some licensed only for rheumatoid arthritis. He is currently wheelchair bound...
Eligibility Criteria
Inclusion
- Subject X, polyarticular JIA, not responding to any other drug
Exclusion
- Not identified subject
Key Trial Info
Start Date :
February 1 2009
Trial Type :
EXPANDED_ACCESS
End Date :
October 1 2010
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00862758
Start Date
February 1 2009
End Date
October 1 2010
Last Update
December 10 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, United States, 73104